Dr. Sergio Rivero, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2450 E River Rd, Tucson, AZ 85718 Phone: 520-795-7750 Fax: 520-320-2155 |
Aaron Burket, D.O. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 4334, Tucson, AZ 85724 Phone: 520-626-7747 |
Dr. Mahmood Hassan, MD, PHD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3935 E Fort Lowell Rd, Tucson, AZ 85712 Phone: 520-333-7190 Fax: 520-333-4180 |
Dr. Wyatt Langdon Ramey, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Room 4303, Tucson, AZ 85724 Phone: 520-626-0704 |
Kurt A Schroeder, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2450 E River Rd, Tucson, AZ 85718 Phone: 520-795-7923 Fax: 520-320-2155 |
Ryan Michael Kretzer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6567 E Carondelet Dr, Suite 305, Tucson, AZ 85710 Phone: 520-881-8400 Fax: 520-881-6563 |
Brian P Callahan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2450 E River Rd, Tucson, AZ 85718 Phone: 520-795-7750 Fax: 520-320-2155 |
News Archive
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
Adolescents who have hypermobile joints or are "double jointed" are more likely to develop moderate to severe joint pain in later years, show study findings.
Speaker Nancy Pelosi held a brief press availability with Chairman Charles Rangel, Chairman Henry Waxman, Chairman George Miller, and Chairwoman Louise Slaughter following their meeting this afternoon with President Obama at the White House to discuss health care legislation.
Luna Innovations Incorporated announced today that it will be extending its development and supply agreement with Intuitive Surgical, Inc. (NASDAQ: ISRG) to continue integrating Luna's shape sensing technology into Intuitive's products.
A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).
› Verified 2 days ago